<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>First licensed treatment to improve healing of tendon injuries and suspensory ligaments in horses</title><link>/b/veterinary-nursing-news/posts/first-licensed-treatment-to-improve-healing-of-tendon-injuries-and-suspensory-ligaments-in-horses</link><description> Boehringer Ingelheim has received UK marketing authorisation for RenuTend - the first licensed treatment to improve healing of tendon injuries and suspensory ligaments in horses. 
 Renutend contains primed mesenchymal stem cells (MSCs) which Boehringer</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>